NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Estimated value
—
Awarded value
—
Suppliers
19
Lots
6
Published
20 Jan 2025
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Scope
- Reference
- CM/PHS/23/5703
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2025 to 31 Dec 2027
- Main category
- goods
- CPV classifications
- 33651520
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 19 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 6 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - Low and High Strength Albumin | £1 | cancelled |
| 2 | Lot 2 - 5% Intravenous Immunoglobulin | £1 | cancelled |
| 3 | Lot 3 - 10% Intravenous Immunoglobulin | £1 | cancelled |
| 4 | Lot 4 - Subcutaneous Immunoglobulin | — | cancelled |
| 5 | Lot 5 - Facilitated Subcutaneous Immunoglobulin | £1 | cancelled |
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Award 5· 1 supplier
Awarded —
Award 6· 1 supplier
Awarded —
Award 7· 1 supplier
Awarded —
Award 8· 1 supplier
Awarded —
Award 9· 1 supplier
Awarded —
Award 10· 1 supplier
Awarded —
Award 11· 1 supplier
Awarded —
Award 12· 1 supplier
Awarded —
Award 13· 1 supplier
Awarded —
Award 14· 1 supplier
Awarded —
Award 15· 1 supplier
Awarded —
Award 16· 1 supplier
Awarded —
Award 17· 1 supplier
Awarded —
Award 18· 1 supplier
Awarded —
Award 19· 1 supplier
Awarded —
Total lots
6
Awarded
5
Estimated total
£5
Awarded total
—
Lot 1 - Low and High Strength Albumin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
£1
CPV
Lot 2 - 5% Intravenous Immunoglobulin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
£1
CPV
Lot 3 - 10% Intravenous Immunoglobulin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
£1
CPV
Lot 4 - Subcutaneous Immunoglobulin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
—
CPV
Lot 5 - Facilitated Subcutaneous Immunoglobulin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
£1
CPV
Lot 6 - Anti-D Immunoglobulin
Start
31 Mar 2025
End
31 Dec 2027
Estimated
£1
CPV
Other contracts from NHS England
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to CSL BEHRING UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Beriplex | contract | £12k | 15 Jul 2026 |
| Medicinal Products and Pharma Funded Homecare [5749446] | contract | — | 17 Jun 2025 |
| NP48925b Hereditary Angioedema Branded Medicines (Berinert) | contract | — | 02 May 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 | contract | — | 22 Apr 2025 |
| NP48925b Hereditary Angioedema Branded Medicines (Berinert) | contract | — | 04 Apr 2025 |
| CSL Behring - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £416k | 12 Mar 2025 |
| NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin | contract | — | 29 Nov 2024 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| NP31523 Albumin Products | contract | — | 09 May 2023 |